Author:
Lauffenburger Julie C.,Mayer Christina L.,Hawke Roy L.,Brouwer Kim L.R.,Fried Michael W.,Farley Joel F.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology,Hepatology
Reference48 articles.
1. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.;Armstrong;Ann Intern Med,2006
2. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.;Muhlberger;BMC Public Health,2009
3. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.;J Hepatol,2014
4. Review and management of drug interactions with boceprevir and telaprevir.;Kiser;Hepatology,2012
5. Telaprevir is a substrate and moderate inhibitor of P-glycoprotein, a strong inductor of ABCG2, but not an activator of PXR in vitro.;Weiss;Int J Antimicrob Agents,2014
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献